Radiation maculopathy complicated by intraretinal neovascularization treated with intravitreal bevacizumab.
OBJECTIVE
The purpose of this study was to describe a case of radiation maculopathy as a result of intraretinal neovascularization, treated with intravitreal bevacizumab.


METHODS
This is an interventional case report. A 51-year-old man was treated with radiotherapy and chemotherapy for nasopharyngeal carcinoma. He developed radiation maculopathy associated with intraretinal neovascularization in the left eye. He underwent a course of 3 intravitreal injections of bevacizumab (1.25 mg/0.05 mL).


RESULTS
The visual acuity in the left eye improved with complete closure of the intraretinal neovascularization and no recurrence 17 months after the last bevacizumab injection.


CONCLUSIONS
This case of radiation-induced intraretinal neovascularization responded well to bevacizumab treatment. These lesions may respond more favorably if treated earlier.
From the *Medical Retina Service, Moorfields Eye Hospital; and †UCL Institute of Ophthalmology, London, United Kingdom.
Waheeda
W
Rahman
Nachiketa
N
Acharya
Mandeep S
MS
Sagoo
Adnan
A
Tufail